INTECH INVESTMENT MANAGEMENT LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1086318 WEST PALM BEACH, FL

Position in HALO

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$12,702,594

+$2,176,694 QoQ

Shares Held

162,292

-0.4% QoQ

Ownership

0.143%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#106

of 664 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 18% Shared 0% None 82%

Healthcare · as of Jun 30, 2026

INTECH INVESTMENT MANAGEMENT LLC holds $204,742,669 across 193 Biotechnology names. HALO ranks #4 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	298,883	$16,262,224
2	INCY	Incyte Corp	141,278	$16,015,273
3	REGN	Regeneron Pharmaceuticals, Inc.	22,260	$13,879,999
4	HALO	Halozyme Therapeutics, Inc. This page	162,292	$12,702,594
5	ALNY	Alnylam Pharmaceuticals, Inc.	36,760	$11,065,862
6	VRTX	Vertex Pharmaceuticals Inc / Ma	20,520	$10,192,899
7	JAZZ	Jazz Pharmaceuticals plc	37,384	$9,008,422
8	TGTX	Tg Therapeutics, Inc.	124,646	$6,848,051

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,702,594	162,292	-0.4%	Shares	Sole	2026-08-10
2026-03-31	$10,525,900	162,864	-17.4%	Shares	Sole	2026-05-08
2025-12-31	$13,273,309	197,226	+32.7%	Shares	Sole	2026-02-10
2025-09-30	$10,903,237	148,667	+46.0%	Shares	Sole	2025-11-12
2025-06-30	$5,296,520	101,817	-33.5%	Shares	Sole	2025-08-08
2025-03-31	$9,775,628	153,199	+9.9%	Shares	Sole	2025-05-20
2024-12-31	$6,665,192	139,410	+147.6%	Shares	Sole	2025-02-11
2024-09-30	$3,222,898	56,305	+147.4%	Shares	Sole	2024-11-08
2024-06-30	$1,191,870	22,763	—	Shares	Sole	2024-08-12
No filing history on record for this holder in this stock.